Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Tuesday - 25 June 2024

Tuesday, 25 June 2024

Ceisteanna (444)

Cathal Crowe

Ceist:

444. Deputy Cathal Crowe asked the Minister for Health the status of the licensing and reimbursement of jorveza; and if he will make a statement on the matter. [26957/24]

Amharc ar fhreagra

Freagraí scríofa

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Roinn